Search research articles
Contact Us
Filters
Showing results (1-10 of 131) with videos related to
Page
of 14
Sort By:
Science (New York, N.Y.)
|
April 30, 2026
AI can reason like a physician-what comes next?
Ashley M Hopkins, Erik Cornelisse
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 3, 2022
Response to Mazzaschi and Buti
Ashley M Hopkins, Michael J Sorich
BMC Medicine
|
September 29, 2018
Data sharing from pharmaceutical industry sponsored clinical studies: audit of data availability
Ashley M Hopkins, Andrew Rowland, Michael J Sorich
Melanoma Research
|
August 20, 2019
Validation of dabrafenib-trametinib prognostic groups in patients treated with vemurafenib and cobimetinib for advanced BRAF-mutated melanoma
Michael J Sorich, Andrew Rowland, Ashley M Hopkins
European Urology
|
September 22, 2020
Reply to Satoshi Funada, Takashi Yoshioka, and Yan Luo's Letter to the Editor re: Ashley M. Hopkins, Ganessan Kichenadasse, Christos S. Karapetis, et al. Concomitant Antibiotic Use and Survival in Urothelial Carcinoma Treated with Atezolizumab. Eur Urol 2020;78:540-3
Ashley M Hopkins, Ganessan Kichenadasse, Michael J Sorich
JAMA Oncology
|
April 24, 2020
Obesity Paradox in Patients With Non-Small Cell Lung Cancer Treated With Immunotherapy-Reply
Ganessan Kichenadasse, Ashley M Hopkins, Michael J Sorich
British Journal of Clinical Pharmacology
|
July 15, 2025
Potential for use of Al/machine learning for pharmacovigilance: Is there a role for regulators?
Christina Gao, Ashley M Hopkins, Andrew Rowland, et al.
JAMA Internal Medicine
|
February 26, 2024
Potential of Large Language Models as Tools Against Medical Disinformation-Reply
Ashley M Hopkins, Bradley D Menz, Michael J Sorich
BMJ (Clinical Research Ed.)
|
March 20, 2024
Quality and safety of artificial intelligence generated health information
Michael J Sorich, Bradley D Menz, Ashley M Hopkins
International Journal of Clinical Oncology
|
May 18, 2020
Effect of early adverse events resulting in sorafenib dose adjustments on survival outcomes of advanced hepatocellular carcinoma patients
Warit Ruanglertboon, Michael J Sorich, Andrew Rowland, et al.
Page
of 14
Search research articles
Search
Showing results (1-10 of 131) with videos related to
Sort By:
Page
of 14
Science (New York, N.Y.)
|
April 30, 2026
AI can reason like a physician-what comes next?
Ashley M Hopkins, Erik Cornelisse
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 3, 2022
Response to Mazzaschi and Buti
Ashley M Hopkins, Michael J Sorich
BMC Medicine
|
September 29, 2018
Data sharing from pharmaceutical industry sponsored clinical studies: audit of data availability
Ashley M Hopkins, Andrew Rowland, Michael J Sorich
Melanoma Research
|
August 20, 2019
Validation of dabrafenib-trametinib prognostic groups in patients treated with vemurafenib and cobimetinib for advanced BRAF-mutated melanoma
Michael J Sorich, Andrew Rowland, Ashley M Hopkins
European Urology
|
September 22, 2020
Reply to Satoshi Funada, Takashi Yoshioka, and Yan Luo's Letter to the Editor re: Ashley M. Hopkins, Ganessan Kichenadasse, Christos S. Karapetis, et al. Concomitant Antibiotic Use and Survival in Urothelial Carcinoma Treated with Atezolizumab. Eur Urol 2020;78:540-3
Ashley M Hopkins, Ganessan Kichenadasse, Michael J Sorich
JAMA Oncology
|
April 24, 2020
Obesity Paradox in Patients With Non-Small Cell Lung Cancer Treated With Immunotherapy-Reply
Ganessan Kichenadasse, Ashley M Hopkins, Michael J Sorich
British Journal of Clinical Pharmacology
|
July 15, 2025
Potential for use of Al/machine learning for pharmacovigilance: Is there a role for regulators?
Christina Gao, Ashley M Hopkins, Andrew Rowland, et al.
JAMA Internal Medicine
|
February 26, 2024
Potential of Large Language Models as Tools Against Medical Disinformation-Reply
Ashley M Hopkins, Bradley D Menz, Michael J Sorich
BMJ (Clinical Research Ed.)
|
March 20, 2024
Quality and safety of artificial intelligence generated health information
Michael J Sorich, Bradley D Menz, Ashley M Hopkins
International Journal of Clinical Oncology
|
May 18, 2020
Effect of early adverse events resulting in sorafenib dose adjustments on survival outcomes of advanced hepatocellular carcinoma patients
Warit Ruanglertboon, Michael J Sorich, Andrew Rowland, et al.
Page
of 14